Comparing our findings of an ER interactome with those previously reported in ER+ breast cancer cells [29,30], only three ER interactors were common to all studies (NCOA3, NCOR2, and TRIM33; Figure 1D). This evidence concerns the gene NCOR2 and breast carcinoma.